Medicine and Dentistry
Multiple Myeloma
100%
Protein Kinase B
75%
Multiple Myeloma Cell Line
75%
Stromal Cell
50%
Mechanistic Target of Rapamycin
50%
Rapamycin
50%
Cytokine
25%
In Vitro
25%
Therapeutic Agent
25%
Tumor Microenvironment
25%
Predictive Marker
25%
Myeloma Cell
25%
Protein Serine Threonine Kinase
25%
Sapanisertib
25%
Keyphrases
Multiple Myeloma
100%
TORC1
100%
Myeloma Cells
50%
Rapamycin
25%
Stromal Cells
25%
AKT1
25%
TORC2
25%
Knockdown
12%
Mammalian Target of Rapamycin (mTOR)
12%
Adhesion
12%
Cellular Processes
12%
Baseline Activity
12%
Tumor Microenvironment
12%
Microenvironment
12%
New Therapeutic Agents
12%
Predictive Marker
12%
PI3K-Akt Pathway
12%
Serine-threonine Kinase
12%
Mammalian Target of Rapamycin Pathway
12%
Clinical Testing
12%
Genetic Abnormalities
12%
AKT/mammalian Target of Rapamycin
12%
4E-BP1
12%
INK128
12%
Neuroscience
Cell Line
100%
Protein Kinase B
100%
In Vivo
66%
Mammalian Target of Rapamycin
66%
Sirolimus
66%
In Vitro
33%
Protein Serine Threonine Kinase
33%
Biochemistry, Genetics and Molecular Biology
Protein Kinase B
100%
Stromal Cell
66%
Mechanistic Target of Rapamycin
66%
Cytokine
33%
Genetics
33%
Kinase
33%
Phosphotransferase
33%
In Vivo Study
33%
Serine
33%
Threonine
33%
Pharmacology, Toxicology and Pharmaceutical Science
Multiple Myeloma
100%
Protein Kinase B
42%
Rapamycin
28%
Mammalian Target of Rapamycin
28%
Cytokine
14%
Tumor Microenvironment
14%
Cellular Processes
14%
Protein Serine Threonine Kinase
14%
Sapanisertib
14%